Developments in Tooling Inspections and Technology - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Developments in Tooling Inspections and Technology
Inspecting punches and dies can be time-consuming and costly for tablet manufacturers. Advances in technology, however, have greatly improved in-process inspections. The author examines improvements in equipment and computer software for in-process tool inspections.


Pharmaceutical Technology


Conclusion

Improvements in tooling management and inspection have been long overdue, and advances in technology bring the tool room into the 21st century. What was once a costly and time-consuming process that often involved storing paper in a file has become an efficient procedure for capturing valuable tooling data that can be used to improve tablet quality. The once-difficult task of analyzing working lengths, the most critical punch dimension, is now incorporated into the inspection process. An entire database of tooling data can be created and maintained with little effort and used to provide information, tool forecasting, and historical analysis. Automated and noncontact inspection systems reduce the risk of punch-tip damage from handling or scratches during the inspection process. Magnified images that highlight tool conditions can be circulated for improved troubleshooting. At last, tool-control functions are using technology to help the tablet manufacturer produce better quality tablets more efficiently.

Robert Caruso is the software support manager at Natoli Engineering, 28 Research Park Circle, St. Charles, MO 63304, tel. 636.926.8900, fax 636.926.8910,

References

1. Tableting Specification Manual, L. Young Ed. (American Pharmacists Association, Washington, DC, 7th edition, 2006).

2. Encyclopedia of Pharmaceutical Technology, Thermal Analysis of Drugs and Drug Products to Unit Processes in Pharmacy: Fundamentals (Vol. 15), J. Swarbrick and J. Boylan, Eds. (Marcel Dekker, New York, 1997).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here